Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer.

Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer.

BACKGROUND: Altered expression of miRNA expression contributes to human carcinogenesis. This study was designed to detect aberrant miRNA expressions as a potential biomarker for early detection and prognosis prediction of non-small cell lung cancer (NSCLC). METHODS: miRNA array was used to profile d...

Full description

Bibliographic Details
Main Authors:	Wangyu Zhu, Jianying He, Dongdong Chen, Bingjie Zhang, Liyun Xu, Haijie Ma, Xiaoguang Liu, Yongkui Zhang, Hanbo Le
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3921142?pdf=render

Similar Items

Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
by: WangYu Zhu, et al.
Published: (2016-01-01)

Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
by: Parisa Bayat, et al.
Published: (2023-02-01)

Expression of miR-302a, miR-302b, miR-302c, miR-302d, miR-367, miR-371, miR-372, miR-373, miR-10b, miR-21 and miR-93 in cells of different histotypes of testicular germ cell tumors
by: M. S. Knyazeva, et al.
Published: (2022-03-01)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
by: Sven H Loosen, et al.
Published: (2019-01-01)

Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma.
by: Xi Zeng, et al.
Published: (2012-01-01)

miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness
by: Tatiana A. Petrova, et al.
Published: (2022-12-01)

miR-93, miR-373, and miR-17-5p Negatively Regulate the Expression of TBP2 in Lung Cancer
by: Ye Li, et al.
Published: (2020-04-01)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
by: Miruna Nemecz, et al.
Published: (2023-09-01)

Association of H-Type Hypertension with miR-21, miR-29, and miR-199 in Kazahks of Xinjiang, China
by: Xin He, et al.
Published: (2022-01-01)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
by: Pernille Bækgaard Udesen1, et al.
Published: (2020-12-01)

Repression of human activation induced cytidine deaminase by miR-93 and miR-155
by: Holton Nathaniel W, et al.
Published: (2011-08-01)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
by: Qiu Shuwei, et al.
Published: (2013-01-01)

Topographic Distribution of miRNAs (miR-30a, miR-223, miR-let-7a, miR-let-7f, miR-451, and miR-486) in the Plasma Extracellular Vesicles
by: Tatiana Petrova, et al.
Published: (2024-02-01)

MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer
by: Sunyoung Park, et al.
Published: (2017-09-01)

The validity of salivary microRNAs (hsa-miR-200a, hsa-miR-125a and hsa- miR-93) as oral squamous cell carcinoma biomarker
by: Shaimaa H Mudhir, et al.
Published: (2014-09-01)

Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in Oral Squamous Cell Carcinoma: A Potential Biomarkers Panel?
by: Ovidiu Aghiorghiesei, et al.
Published: (2022-04-01)

Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer
by: Qian Zhang, et al.
Published: (2023-10-01)

Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients
by: Matthias Bache, et al.
Published: (2023-08-01)

The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization
by: Reza Keikha, et al.
Published: (2021-07-01)

The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer
by: Bolayırlı Ibrahim Murat, et al.
Published: (2022-01-01)

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression.
by: Kristoffer Unterbruner, et al.
Published: (2018-01-01)

Expression of MicroRNAs (miR-15b, miR-16, miR-138, miR-221, and miR-222) as Biomarkers of Endothelial Corpus Cavernosum Dysfunction in a Diabetic Alcoholic Murine Model
by: Ricardo Brianezi Tiraboschi, MD, PhD, et al.
Published: (2021-04-01)

Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202
by: Ali Gheysarzadeh, et al.
Published: (2018-01-01)

Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer
by: Dahu Wang, et al.
Published: (2015-10-01)

Diagnostic performance of miR-21, miR-124, miR-132, and miR-200b serums in post-stroke cognitive impairment patients
by: Mei Yuan, et al.
Published: (2022-06-01)

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
by: Oshrat Hershkovitz Rokah, et al.
Published: (2012-01-01)

Expression of miR-145, miR-146, and miR-155 in an experimental model of arteriovenous fistula
by: Hugo Laparra-Escareño, et al.
Published: (2022-01-01)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
by: Elena Coccia, et al.
Published: (2020-12-01)

Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
by: Parisa Naeli, et al.
Published: (2017-11-01)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
by: Camile B. Lopes, et al.
Published: (2018-07-01)

Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4⁺ T cells and peripheral blood from tuberculosis patients.
by: Katja Kleinsteuber, et al.
Published: (2013-01-01)

Bioinformatics analysis of the common targets of miR-223-3p, miR-122-5p, and miR-93-5p in polycystic ovarian syndrome
by: Liping Zou, et al.
Published: (2023-02-01)

Salivary microRNAs (hsa-miR-200a, hsa-miR-125a and hsa- miR-93) in relation to age, gender and histopathological parameters.
by: Shaimaa H Mudhir, et al.
Published: (2014-12-01)

Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients
by: Farzaneh Raeisi, et al.
Published: (2020-03-01)

Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
by: Bo-sheng Li, et al.
Published: (2012-01-01)

Circulating extracellular miR-22, miR-155, and miR-365 as candidate biomarkers to assess transport-related stress in turkeys
by: C. Lecchi, et al.
Published: (2016-01-01)

Expression pattern of miR-193a, miR122, miR155, miR-15a, and miR146a in peripheral blood mononuclear cells of children with obesity and their relation to some metabolic and inflammatory biomarkers
by: Maryam Behrooz, et al.
Published: (2023-03-01)

MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer
by: Ewa Ciszkowicz, et al.
Published: (2020-08-01)

Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy
by: Paweł Rubiś, et al.
Published: (2019-11-01)

MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
by: Dorota Jesionek-Kupnicka, et al.
Published: (2019-03-01)